Related Experiment Video

Updated: May 11, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

[Study on the height and weight in children with obstructive sleep apnea hypopnea syndrome]

Yong Zeng1, Yuejian Wang, Weixiong Chen

  • 1Department of Otorhinolaryngology Head and Neck Surgery, the First People's Hospital of Foshan, Foshan, 528000, China. zyong@fsyyy.com

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery
|May 2, 2013
PubMed

Insights

Obstructive sleep apnea hypopnea syndrome (OSAHS) in children stunts growth by reducing growth hormone. Surgery improves sleep quality, normalizes growth hormone, and allows children to catch up in height and weight.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Otolaryngology

Context:

  • Obstructive sleep apnea hypopnea syndrome (OSAHS) is increasingly recognized as a condition affecting children's overall health.
  • Growth impairment is a potential but not fully understood consequence of OSAHS in pediatric populations.

Purpose:

  • This study aimed to investigate the impact of OSAHS on the growth parameters of children.
  • The research specifically examined the relationship between OSAHS, growth hormone secretion, and physical growth (height and weight).

Summary:

  • Children diagnosed with OSAHS exhibited significantly lower height and weight compared to healthy controls.
  • Sleep studies (PSG) revealed decreased blood oxygen saturation in OSAHS patients.
  • Growth hormone levels were significantly lower in children with OSAHS, but normalized three months after surgical intervention (tonsillectomy or adenoidectomy).

Impact:

  • Findings highlight that upper airway obstruction in OSAHS negatively affects sleep quality, leading to reduced growth hormone secretion and consequently, impaired growth.
  • Early surgical intervention is crucial for alleviating OSAHS symptoms, normalizing growth hormone levels, and enabling catch-up growth in height and weight.
Abstract

More Related Videos

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

A Model to Simulate Clinically Relevant Hypoxia in Humans09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...